Sign In
Buy ADC
$78.62
+0.670 (+0.86%)
At Close: Jul 13, 2026
The REIT Strategy I Would Use To Retire Today
07:15am, Saturday, 11'th Jul 2026
Retirement income requires more than just high yield. REIT funds may not be the best solution. A balanced REIT portfolio can offer income and growth.
The 12.9% Monthly Dividend That Quietly Eats Your Portfolio
12:10pm, Thursday, 09'th Jul 2026
In the working world, paychecks show up every two weeks. Or at least, every month.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
09:56am, Tuesday, 07'th Jul 2026
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in China
09:00pm, Sunday, 05'th Jul 2026
BEIJING, July 05, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today
5 Safe Monthly Pay Dividend Stocks Boomers Love in July
09:00am, Sunday, 05'th Jul 2026
Income investors heading into July face a friendlier setup than they did just six weeks ago.
My 5 Greatest REIT Winners Of All Time
08:00am, Saturday, 04'th Jul 2026
Iron Mountain, Tanger, Four Corners, Essential Properties, and Chatham Lodging delivered outsized REIT returns by exploiting price-value gaps during market panics. My disciplined value investing appro
ADC Therapeutics Announces New Employee Inducement Grant
04:05pm, Wednesday, 01'st Jul 2026
LAUSANNE, Switzerland, July 1, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced tha
Agree Realty Announces Second Quarter 2026 Earnings Release Date and Conference Call Information
05:01pm, Tuesday, 30'th Jun 2026
Agree Realty Corporation (NYSE: ADC) (the âCompanyâ) today announced that it will release its second quarter 2026 operating results after the market closes
Agree Realty Announces Second Quarter 2026 Earnings Release Date and Conference Call Information
04:05pm, Tuesday, 30'th Jun 2026
ROYAL OAK, Mich.--(BUSINESS WIRE)--Agree Realty Corporation (NYSE: ADC) (the “Company”) today announced that it will release its second quarter 2026 operating results after the market closes on Th
ADC Therapeutics Announces Completion of Enrollment in LOTIS-7 Phase 1b ZYNLONTA® Combination Trial
07:15am, Tuesday, 30'th Jun 2026
100 r/r DLBCL patients treated at the selected 150 µg/kg dose of ZYNLONTA® plus glofitamab Full data expected in fourth quarter of 2026 LAUSANNE, Switzerland, June 30, 2026 /PRNewswire/ -- ADC Thera
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
10:00am, Thursday, 25'th Jun 2026
NEW YORK, June 25, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA ("ADC" or the "Company") (NYSE: ADCT). Such investors are advised to contact
ADC Therapeutics Announces Strategic Reorganization to Support ZYNLONTA® Growth Opportunities and Regulatory Priorities
07:30am, Wednesday, 24'th Jun 2026
Planned ~17% workforce reduction expected to generate annualized estimated savings of approximately $10M, enhancing financial flexibility Company focused on delivering upcoming regulatory and clinical
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
05:50pm, Tuesday, 23'rd Jun 2026
NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of ADC Therapeutics SA (“ADC” or the “Company”) (NYSE: ADCT). Such investors are advise
AU, Switzerland & PRINCETON, N.J.--(BUSINESS WIRE)--Araris Biotech AG, a company advancing a differentiated pipeline of antibody-drug conjugates (“ADCs”) therapies, and Taiho Oncology, Inc., a com
PARIS--(BUSINESS WIRE)-- #adc--One Biosciences receives Paris-Saclay Cancer Cluster (PSCC) BOOST grant to develop first single-cell assay for antibody-drug conjugates therapies.
